Eugene A. Woltering, MD, Program Leader
The clinical research program selects emerging therapies and strategies to offer to our patients as experimental alternatives to routine care. We test new drugs and new strategies developed by our LCRC faculty and by collaborating colleagues throughout the world. We are members of seven federally funded cooperative research groups and collaborate with industry in drug development.
Among our various activities, we operate a National Cancer Institute (NCI)-funded Minority Based Community Clinical Oncology Program (MB-CCOP), through which we provide opportunities for minority and other cancer patients to participate in state-of-the-art clinical trials.